NRP1 and COVID-19: Another single cell study [167] comparing the snRNA-Seq profiles of COVID-19-infected AD patients and COVID-19-infected cognitively normal individuals found that two SARS-CoV-2 docking receptors, NRP1 and BSG, had elevated expression in endothelial cells in the prefrontal cortex of both AD patients and healthy controls compared to other brain cell types.